AXQ Capital’s Mirum Pharmaceuticals MIRM Stock Holding History

AXQ Capital’s Portfolio MIRM Stock Details MIRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-5,695	Closed	-$290K	–	736
2025 Q2	$290K	Buy	+5,695	New	+$254K	0.09%	365

Other funds holding MIRM

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

AXQ Capital's MIRM Position: Q3 2025 in Review

AXQ Capital sold out of Mirum Pharmaceuticals (MIRM) in Q3 2025, closing a stake of 5,695 shares — an estimated $290K sold.

AXQ Capital first reported a position in MIRM in Q2 2025 and held it in 1 quarter. The position peaked at $290K in Q2 2025. 272 funds tracked by Wall St. Rank hold MIRM as of Q3 2025.

AXQ Capital reported no remaining Mirum Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
AXQ Capital sold 5,695 Mirum Pharmaceuticals shares in Q3 2025, an estimated $290K.
AXQ Capital first reported a position in Mirum Pharmaceuticals in Q2 2025 and held it in 1 quarter.
AXQ Capital's Mirum Pharmaceuticals position peaked at $290K in Q2 2025.
272 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q3 2025.

Based on AXQ Capital's 13F filing for Q3 2025, filed 10 Nov 2025.